We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+4.77%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$63.3M
AUM Growth
-$2.59M
(-3.9%)
Cap. Flow
+$19.8M
Cap. Flow
% of AUM
31.36%
Top 10 Holdings %
Top 10 Hldgs %
52.91%
Holding
597
New
216
Increased
73
Reduced
139
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.52M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$1.06M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$219K |
| 4 |
Radian Group
RDN
|
+$215K |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$211K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.2M |
| 2 |
Eli Lilly
LLY
|
+$980K |
| 3 |
Amgen
AMGN
|
+$598K |
| 4 |
Invesco QQQ Trust
QQQ
|
+$417K |
| 5 |
Franklin Resources
BEN
|
+$328K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.52% |
| 2 | Healthcare | 8.8% |
| 3 | Consumer Discretionary | 5.85% |
| 4 | Real Estate | 5.58% |
| 5 | Industrials | 5.45% |
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q3 2018 Portfolio in Review
As of Q3 2018, TLP Group held 597 positions worth $63.3M, down 3.9% from $65.8M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
TLP Group deployed $19.8M of net new capital in Q3 2018, opening 216 new positions and adding to 73 existing holdings. Its largest new stake was iShares US Real Estate ETF: 13,060 shares worth $1.04M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $980K trimmed.
- TLP Group's largest Q3 2018 buy was iShares US Real Estate ETF: 13,060 shares worth $1.04M.
- TLP Group added most to iShares Russell 2000 ETF in Q3 2018, an estimated $1.52M increase.
- TLP Group's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $980K.
- TLP Group fully exited Pfizer in Q3 2018, selling an estimated $4.2M.
- TLP Group's ten largest holdings make up 53% of its $63.3M portfolio in Q3 2018.
- TLP Group opened 216 new positions and closed 153 in Q3 2018.
- TLP Group's portfolio value fell 3.9% quarter-over-quarter to $63.3M.
Based on TLP Group's 13F filing for Q3 2018, filed 14 Nov 2018.